Ambu A/S
CSE:AMBU B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ambu A/S
Revenue
Ambu A/S
Revenue Peer Comparison
Ambu A/S
Glance View
Ambu A/S makes single-use medical devices used mainly in hospitals and clinics. Its best-known products are disposable endoscopes, airway management tools such as laryngeal masks and resuscitators, and devices used to monitor patients during medical procedures. The company sells into the healthcare supply chain, where doctors, nurses, and hospital buyers choose products that are ready to use and do not need to be cleaned or reprocessed after each patient. Ambu makes money by selling these devices to hospitals, surgical centers, and other medical providers through distributors and direct sales teams. The core of the business is the shift from reusable equipment to disposable tools, especially in endoscopy, where Ambu has built a strong position with single-use scopes that can reduce contamination risk and simplify workflow. That makes Ambu different from traditional device makers that depend more on reusable products and service contracts. The company’s role is to supply practical, procedure-focused equipment that helps clinicians treat patients quickly and safely. Demand is tied to everyday medical procedures rather than consumer demand, so the business depends on healthcare spending, purchasing decisions by hospital systems, and adoption of disposable alternatives in clinical practice.
See Also
What is Ambu A/S's Revenue?
Revenue
6.1B
DKK
Based on the financial report for Dec 31, 2025, Ambu A/S's Revenue amounts to 6.1B DKK.
What is Ambu A/S's Revenue growth rate?
Revenue CAGR 5Y
10%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Ambu A/S have been 10% over the past three years , 10% over the past five years .